SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Competition and price among brand-name drugs in the same class: A systematic review of the evidence
15 references·0 citing·50 second hop
Competition and price among brand-name drugs in the same class: A systematic review of the evidence (2019)Competition and price among brand-name dr…National Health Expenditure Projections, 2017–26: Despite Uncertainty, Fundamentals Primarily Drive Spending Growth (2018)National Health Expenditure P…Trajectories of Injectable Cancer Drug Costs After Launch in the United States (2017)Trajectories of Injectable Ca…Prices of Generic Drugs Associated with Numbers of Manufacturers (2017)Prices of Generic Drugs Assoc…The High Cost of Prescription Drugs in the United States (2016)The High Cost of Prescription…The cost of multiple sclerosis drugs in the US and the pharmaceutical industry (2015)The cost of multiple sclerosi…Pricing in the Market for Anticancer Drugs (2015)Pricing in the Market for Ant…Signaling Status with Luxury Goods: The Role of Brand Prominence (2010)Signaling Status with Luxury …Physician Awareness of Drug Cost: A Systematic Review (2007)Physician Awareness of Drug C…Price Competition in Pharmaceuticals: The Case of Anti‐infectives (2004)Price Competition in Pharmace…The Centers for Medicare and Medicaid Services (2001)The Centers for Medicare and …Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs (1999)Advertising and Competition i…Strategic Pricing of New Pharmaceuticals (1998)Strategic Pricing of New Phar…The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry (1994)The Roles of Marketing, Produ…Theory of Industrial Organization. (1989)Theory of Industrial Organiza…The Theory of Industrial Organization (1988)The Theory of Industrial Orga…Optimal Advertising Policy Under Dynamic Conditions (1976)Patent Expiration, Entry, and Competition in the U.S. Pharmaceutical Industry (1991)Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act (1992)Diffusion of new pharmaceutical drugs in developing and developed nations (2004)Regulation and pricing of pharmaceuticals: Reference pricing or price cap regulation? (2008)Measuring performance in off-patent drug markets: A methodological framework and empirical evidence from twelve EU Member States (2014)A New Product Growth for Model Consumer Durables (1969)A New Product Growth Model for Consumer Durables (1976)Health Care Financing Review (1980)Parallel imports and the pricing of pharmaceutical products: evidence from the European Union (2004)The Economics of Follow-on Drug Research and Development (2004)The Pharmaceutical Industry (2013)Mental Accounting and Consumer Choice (1985)Fairness as a Constraint on Profit Seeking: Entitlements in the Market (2000)Mental Accounting and Consumer Choice (2008)The high price of anticancer drugs: origins, implications, barriers, solutions (2017)Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies (2019)How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment (2021)What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)Limits on Medicare's Ability to Control Rising Spending on Cancer Drugs (2009)The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts (2013)Dynamic Learning of Patient Response Types: An Application to Treating Chronic Diseases (2017)Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA (2017)Pricing of pharmaceuticals is becoming a major challenge for health systems (2020)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons (2001)Mode of questionnaire administration can have serious effects on data quality (2005)Determinants of Self-Reported Medicine Underuse Due to Cost: A Comparison of Seven Countries (2010)A Drug Utilization Study of Psychotropic Drugs Prescribed in the Psychiatry Outpatient Department of a Tertiary Care Hospital (2013)Survey Finds Few Orthopedic Surgeons Know The Costs Of The Devices They Implant (2014)Negation in syntax: on the nature of functional categories and projections (1991)Autolexical syntax : A theory of parallel grammatical representations. By Jerrold M. Sadock Chicago: University of Chicago Press, 1991. Pp. 254. (1997)The Incumbent's Curse? Incumbency, Size, and Radical Product Innovation (2000)Organizational Knowledge Creation Theory: Evolutionary Paths and Future Advances (2006)Verb Movement, Universal Grammar, and the Structure of IP, 1989 (2013)Diagnosing the decline in pharmaceutical R&D efficiency (2012)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Self-Concept in Consumer Behavior: A Critical Review (1982)Possessions and the Extended Self (1988)Brand Community (2001)Why Do Consumers Buy Counterfeit Luxury Brands? (2009)Between the mass and the class: Antecedents of the “bandwagon” luxury consumption behavior (2011)What is a luxury brand? A new definition and review of the literature (2017)A Model of Growth Through Creative Destruction (1992)General purpose technologies ‘Engines of growth’? (1995)International Norm Dynamics and Political Change (1998)Confronting The Barriers To Chronic Care Management In Medicare (2003)Inequality of Access to Surgical Specialty Health Care: Why Children With Government-Funded Insurance Have Less Access Than Those With Private Insurance in Southern California (2004)Physician Payment 2008 for Interventionalists: Current State of Health Care Policy (2007)
this work references cited by second hop

References

  • 1988The Theory of Industrial Organization8,578 cited
  • 1989Theory of Industrial Organization.5,142 cited
  • 2010Signaling Status with Luxury Goods: The Role of Brand Prominence1,657 cited
  • 2016The High Cost of Prescription Drugs in the United States591 cited
  • 2001The Centers for Medicare and Medicaid Services550 cited
  • 2015Pricing in the Market for Anticancer Drugs452 cited
  • 2007Physician Awareness of Drug Cost: A Systematic Review292 cited
  • 2015The cost of multiple sclerosis drugs in the US and the pharmaceutical industry261 cited
  • 1998Strategic Pricing of New Pharmaceuticals249 cited
  • 1999Advertising and Competition in the Ethical Pharmaceutical Industry: The Case of Antihypertensive Drugs176 cited
  • 2018National Health Expenditure Projections, 2017–26: Despite Uncertainty, Fundamentals Primarily Drive Spending Growth125 cited
  • 2004Price Competition in Pharmaceuticals: The Case of Anti‐infectives118 cited
  • 1994The Roles of Marketing, Product Quality and Price Competition in the Growth and Composition of the U.S. Anti-Ulcer Drug Industry111 cited
  • 2017Trajectories of Injectable Cancer Drug Costs After Launch in the United States108 cited
  • 2017Prices of Generic Drugs Associated with Numbers of Manufacturers

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

93 cited

Cited by

No citing works inside the corpus for this window.